<SEC-DOCUMENT>0000950170-25-097279-index.html : 20250721
<SEC-HEADER>0000950170-25-097279.hdr.sgml : 20250721
<ACCEPTANCE-DATETIME>20250721164134
ACCESSION NUMBER:		0000950170-25-097279
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250717
FILED AS OF DATE:		20250721
DATE AS OF CHANGE:		20250721

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Abdun-Nabi Daniel
		CENTRAL INDEX KEY:			0001380187
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37746
		FILM NUMBER:		251137702

	MAIL ADDRESS:	
		STREET 1:		2401 4TH AVENUE
		STREET 2:		SUITE 1050
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aptevo Therapeutics Inc.
		CENTRAL INDEX KEY:			0001671584
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				811567056
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2401 4TH AVE.
		STREET 2:		SUITE 1050
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		206-838-0500

	MAIL ADDRESS:	
		STREET 1:		2401 4TH AVE.
		STREET 2:		SUITE 1050
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>